Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Phase 4CompletedNCT00377546

Innovative Medical

Overview

To compare the penetration of three different NSAIDs.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Vitrectomy

Interventions

NepafenacDRUG

Ketorolac LS, BromfenacDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Males or females scheduled to undergo Vitrectomy surgery * Likely to complete all study visits and able to provide informed consent * Visual potential of 20/25 or better Exclusion Criteria: * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease * Active ocular allergies

Locations (1)

Ophthalmic Consultants of Boston

Boston, Massachusetts, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.